Adell Harriman & Carpenter’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $252K | Buy |
480
+4
| +0.8% | +$2.1K | 0.02% | 157 |
|
|
2025
Q1 | $302K | Sell |
476
-27
| -5% | -$17.1K | 0.02% | 150 |
|
|
2024
Q4 | $358K | Hold |
503
| – | – | 0.02% | 138 |
|
|
2024
Q3 | $529K | Hold |
503
| – | – | 0.04% | 121 |
|
|
2024
Q2 | $529K | Sell |
503
-4
| -0.8% | -$4.2K | 0.04% | 117 |
|
|
2024
Q1 | $488K | Hold |
507
| – | – | 0.04% | 128 |
|
|
2023
Q4 | $445K | Buy |
507
+126
| +33% | +$111K | 0.04% | 123 |
|
|
2023
Q3 | $314K | Hold |
381
| – | – | 0.03% | 141 |
|
|
2023
Q2 | $274K | Sell |
381
-8
| -2% | -$5.75K | 0.03% | 150 |
|
|
2023
Q1 | $320K | Buy |
389
+32
| +9% | +$26.3K | 0.03% | 145 |
|
|
2022
Q4 | $258K | Hold |
357
| – | – | 0.03% | 156 |
|
|
2022
Q3 | $246K | Buy |
+357
| New | +$246K | 0.03% | 157 |
|
|
2022
Q2 | – | Sell |
-360
| Closed | -$251K | – | 166 |
|
|
2022
Q1 | $251K | Sell |
360
-1
| -0.3% | -$698 | 0.02% | 160 |
|
|
2021
Q4 | $228K | Buy |
+361
| New | +$228K | 0.02% | 170 |
|